MAPT and Alzheimer disease: However, recent developments in newly generated animal models of AD have recapitulated substantial synaptic and neuron loss, notably the R962-hTau transgenic rat line (Malcolm et al., 2019) and the P301S/E4 transgenic mouse line (Shi et al., 2017), by incorporating FTD-linked tau mutations.